FY 2026 drug court training and technical assistance competitive cooperative agreement solicitation

Closed Posted

Opportunity number
DCT-DCT-26-001
Agency
Applications due
Award size
$6,000,000

Opportunity facts

Funding instrument
Cooperative Agreement
Category
  • Law, Justice and Legal Services
Eligible applicants
  • 501(c)(3) Nonprofits
Full announcement

Opportunity details come from Grants.gov. Updated .

About this opportunity

The Office of the National Drug Control Policy is soliciting applications for a competitive cooperative agreement providing $6 million over 24 months to support training and technical assistance for drug court practitioners on evidence-based addiction treatment, with an application deadline of August 27, 2026. One award is expected. Eligible applicants are 501(c)(3) nonprofits with demonstrated expertise in training criminal justice practitioners on evidence-based treatment for justice-involved individuals with addiction and co-occurring mental health conditions; joint applications from multiple eligible entities are welcome with one designated as primary.

Recipients must provide no-cost, on-request training and technical assistance at local, state, tribal, regional, and national levels through in-person and online modalities, serving geographically distributed areas including rural locations. Core requirements include designating and funding an independent research or academic organization to assess training effectiveness, developing curricula and technical assistance protocols, maintaining a directory of TTA experts, producing at least two new TTA materials annually, and ensuring close alignment with the Trump Administration's policy priorities and the 2026 National Drug Control Strategy, including FDA-approved medications for opioid use disorder and naloxone distribution.

All applicants must secure participation from addiction medicine experts and licensed behavioral health practitioners. Merit review uses a 100-point scale: Statement of Problem (10 points), Program Design and Implementation (40 points), Capabilities and Competencies (50 points, with 30 allocated to management structure, staffing, and capacity), Budget and Budget Narrative (10 points), and Performance Measure Data Collection (10 points). The program narrative is limited to 20 pages. Recipients must submit quarterly progress reports and Federal Financial Reports within 30 days of quarter close and 90 days at project completion. Award announcement is expected in September 2026 (CFDA 95.005).

Synopsis

ONDCP's Drug Court Training and Technical Assistance Cooperative Agreement supports training and technical assistance (TTA) to ensure access to evidence-based addiction treatment through drug courts, including when substance use disorder co-occurs with other mental healthconditions. ONDCP seeks to reduce drug use and its consequences through evidence-based treatment that leads to long-term recovery, and this cooperative agreement will support the President's priorities by applying this to the criminal justice system. The purpose of this cooperative agreement is to: (1) educate, train, and produce materials to improve the implementation of evidence-based treatment to individuals with addiction, including when substance use disorder co-occurs with other mental health conditions; (2)decrease criminal justice costs and recidivism rates; and (3) improve access to evidence-based addiction treatment that includes medications for opioid use disorder through drug courts. The cooperative agreement recipient shall:• Use expert practitioners in the science of addiction and evidence-based addiction treatment, as well as integration of treatment into the criminal justice system.• Use licensed behavioral health practitioners.• Provide in-person training, online training, and jurisdiction-specific technical assistanceto a wide range of geographically distributed areas-including rural locations-at thestate, local, and tribal levels.• Ensure close alignment of all TTA materials with the Trump Administration's policy priorities, including the 2026 National Drug Control Strategy; an evidence-based approach to treating addiction--to include FDA-approved medications for opioid use disorder--contingency management, and other evidence-based behavioral health modalities for other substance use disorders; naloxone distribution and naloxone training.• Designate and fund a research or academic organization to conduct an independent assessment of the effectiveness and impact of training and technical assistance conducted under this cooperative agreement. The independent study should involve data collectionfrom state, local, and tribal jurisdictions engaged in cooperative agreement recipient programming.

Files

File Type Posted
FY 2026 Drug Courts TTA Grants.gov Posting NOFO.pdf PDF

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar grant opportunities
  • Ask GovTribe AI about this opportunity